Trained Immunity in Fungal Infection and Its Mechanism
- Conditions
- BCG Vaccination
- Interventions
- Registration Number
- NCT06628544
- Lead Sponsor
- Zhongnan Hospital
- Brief Summary
Investigator vaccinated 76 healthy BCG-naive participant with BCG, while 3 participants received. Half of BCG-vaccinated participants (n = 38) received an incremental dose of metformin for 6 days (up to 1,000 mg twice daily on day 6). On the day 0 (total 20; n = 10 for BCG vaccination, n = 10 for BCG vaccination plus taking metformin), day 14 (total 30; n=15 for BCG vaccination, n = 15 for BCG vaccination plus taking metformin), day 90 (total 26; n = 13 for BCG vaccination, n=13 for BCG vaccination plus taking metformin) of BCG vaccination, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
- Healthy BCG-naive participants.
- The ages range from 20 to 45.
- Participants without any infections or immune deficiencies.
- Participants when infections or other illnesses occurred during the clinical trial.
- Participants who have a fever of unknown causes during the clinical trial.
- Participants who have gotten other vaccines during the clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description BCG vaccination with taking metformin on the day 9 Metformin is administered on the day 9 - BCG vaccination without metformin BCG vaccination - BCG vaccination with taking metformin on the day 85 BCG vaccination - BCG vaccination with taking metformin on the day 85 Metformin is administered on the day 85 - Placebo Placebo - BCG vaccination with taking metformin on the day 0 BCG vaccination - BCG vaccination with taking metformin on the day 0 Metformin is administered on the day 0 - BCG vaccination with taking metformin on the day 9 BCG vaccination -
- Primary Outcome Measures
Name Time Method The level of IL-6 Five days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.
The level of TGF-alpha Five days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Wuhan University
🇨🇳Wuhan, Hubei, China, China